Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Cold Water Tolerance
NCT05990387Phase 2Completed
- Sponsor
- Indiana University
- Start
- Jul 2023
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
A Phase 2 trial of mirabegron in Hypothermia, sponsored by Indiana University. Started Jul 2023; status: completed.
02
Drugs
mirabegron
03
Conditions
Hypothermia
Beyond the preview
Go deeper on NCT05990387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990387.